These PDXs had varying levels of ER positivity and responses to E2 including: E2‐dependent (SC31,15 GS4), ‐accelerating (SC1,15 GS1, GS2) and ‐suppressed (GS314) tumours (Figure S3A). This evidence concerns the gene ESR1 and neoplasm.